Generic Portal

— Research Explorer

MART-1 TCR gene-modified peripheral blood T cells for the treatment of metastatic melanoma: a phase I/IIa clinical trial

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Article number	100089
Journal	Immuno-Oncology and Technology
Volume	15
DOIs	https://doi.org/10.1016/j.iotech.2022.100089
Publication status	Published - 1 Sept 2022

MART-1, T-cell receptor gene therapy, adoptive cell therapy, immunotherapy, melanoma, uveal

ID: 25081186